Avadel Pharmaceuticals (AVDL) Leases: 2017-2022
Historic Leases for Avadel Pharmaceuticals (AVDL) over the last 5 years, with Sep 2022 value amounting to $1.9 million.
- Avadel Pharmaceuticals' Leases fell 5.94% to $1.9 million in Q3 2022 from the same period last year, while for Sep 2022 it was $1.9 million, marking a year-over-year decrease of 5.94%. This contributed to the annual value of $2.7 million for FY2021, which is 1.84% up from last year.
- As of Q3 2022, Avadel Pharmaceuticals' Leases stood at $1.9 million, which was down 10.69% from $2.2 million recorded in Q2 2022.
- In the past 5 years, Avadel Pharmaceuticals' Leases ranged from a high of $6.0 million in Q3 2018 and a low of $1.9 million during Q3 2022.
- In the last 3 years, Avadel Pharmaceuticals' Leases had a median value of $2.4 million in 2021 and averaged $2.5 million.
- Its Leases has fluctuated over the past 5 years, first surged by 73.46% in 2018, then tumbled by 42.85% in 2020.
- Avadel Pharmaceuticals' Leases (Quarterly) stood at $5.0 million in 2018, then dropped by 28.42% to $3.6 million in 2019, then decreased by 27.91% to $2.6 million in 2020, then grew by 1.84% to $2.7 million in 2021, then fell by 5.94% to $1.9 million in 2022.
- Its Leases stands at $1.9 million for Q3 2022, versus $2.2 million for Q2 2022 and $2.4 million for Q1 2022.